MARKET

CTLT

CTLT

Catalent
NYSE

Real-time Quotes | Nasdaq Last Sale

88.41
+0.61
+0.69%
After Hours: 90.09 +1.68 +1.90% 16:19 08/13 EDT
OPEN
87.51
PREV CLOSE
87.80
HIGH
88.86
LOW
87.13
VOLUME
580.66K
TURNOVER
--
52 WEEK HIGH
91.18
52 WEEK LOW
31.04
MARKET CAP
14.39B
P/E (TTM)
119.02
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CTLT stock price target is 93.67 with a high estimate of 110.00 and a low estimate of 62.00.

EPS

CTLT News

More
Catalent (CTLT) is a Critical Partner to Develop COVID-19 Vaccine
Insider Monkey · 07/31 17:09
Catalent cheers Q4 prelims
Seeking Alpha - Article · 07/30 13:07
Catalent shares are trading higher after the company issued Q4 and FY20 sales guidance above analyst estimates.
Benzinga · 07/30 12:23
Catalent Sees Q4 Adj. EBITDA $262M-$266M, Sales $937M-$949M vs $776.7M Estimate; FY20 Adj. EBITDA $745M-$749M, Sales $3.084B-$3.096B vs $2.92B Est.
Benzinga · 07/30 12:15
Catalent, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Fiscal Year 2020 Net Revenue, Earnings Before Income Taxes, and Adjusted EBITDA Significantly Ahead of Its Previous Guidance
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that, given the fluidity created b
Business Wire · 07/30 12:13
Editas taps Catalent to supply lineup of products
Seeking Alpha - Article · 07/29 14:32
Coronavirus Vaccine Stocks: Investors Cannot Overlook These Risks
MotleyFool.com · 07/29 12:11
The Race To Erase COVID-19
Seeking Alpha - Article · 07/29 05:21

Industry

Pharmaceuticals
-0.43%
Pharmaceuticals & Medical Research
-0.01%

Hot Stocks

Symbol
Price
%Change

About CTLT

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.
More

Webull offers kinds of Catalent Inc stock information, including NYSE:CTLT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTLT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CTLT stock methods without spending real money on the virtual paper trading platform.